register

Sales

The science of successful sales transformation

Health Industry Hub | June 18, 2019 |
[Total: 1    Average: 4/5]

Data and analytics, combined with a personalised approach to performance management, are helping sales execs inculcate best practices and significantly improve growth.

The pharmaceutical market in Australia is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 2%, while the medical device market is projected to grow at a CAGR of 0.1% to $11.44 billion by 2020. Price cuts, funding and reimbursement challenges hinder growth making it even more important for organisations to sharpen their sales performance.

Despite years of championing transformation initiatives, too many sales organisations still struggle with lackluster performance. Advances in the “science” of change – digital, analytics, and supporting methodologies – can make a big difference, increasing the odds of success three to four times. 


Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]

More


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]

More


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]

More


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]

More